Goldman Sachs
ZURA icon

Goldman Sachs’s Zura Bio ZURA Stock Holding History

Goldman Sachs’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$910K Sell
152,915
-63,895
-29% -$386K ﹤0.01% 5157
2025
Q4 		$1.14M Buy
216,810
+135,087
+165% +$534K ﹤0.01% 5049
2025
Q3 		$354K Sell
81,723
-220,968
-73% -$397K ﹤0.01% 5685
2025
Q2 		$318K Buy
302,691
+179,715
+146% +$215K ﹤0.01% 5407
2025
Q1 		$159K Sell
122,976
-21,107
-15% -$33.3K ﹤0.01% 5681
2024
Q4 		$360K Buy
144,083
+46,709
+48% +$166K ﹤0.01% 5415
2024
Q3 		$395K Buy
+97,374
New +$364K ﹤0.01% 5178
2024
Q1 		– Sell
-19,458
Closed -$90.9K – 5931
2023
Q4 		$90.9K Buy
19,458
+2,002
+11% +$10K ﹤0.01% 5308
2023
Q3 		$115K Buy
+17,456
New +$117K ﹤0.01% 5158

Other funds holding ZURA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Goldman Sachs's ZURA Position: Q1 2026 in Review

Goldman Sachs reduced its Zura Bio (ZURA) stake by 29% in Q1 2026, selling an estimated $386K and leaving 152,915 shares worth $910K. The position accounts for ﹤0.01% of the portfolio, ranked #5157.

Goldman Sachs first reported a position in ZURA in Q3 2023 and has held it in 9 quarters since. The position peaked at $1.14M in Q4 2025. 94 funds tracked by Wall St. Rank hold ZURA as of Q1 2026.

  • Goldman Sachs held 152,915 shares of Zura Bio worth $910K as of Q1 2026.
  • Goldman Sachs sold 63,895 Zura Bio shares in Q1 2026, an estimated $386K.
  • Zura Bio made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #5157 holding.
  • Goldman Sachs first reported a position in Zura Bio in Q3 2023 and has held it in 9 quarters since.
  • Goldman Sachs's Zura Bio position peaked at $1.14M in Q4 2025.
  • 94 funds tracked by Wall St. Rank held Zura Bio as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.